E-LIB Suche - Ergebnisse für: Soulard, S.

1

HSD2 Reusable Soft Mist Inhalers Have an Improved Carbon Fo..:

Janson, C ; Hernando Platz, J ; Soulard, S...
Value in Health. 25 (2022) 12 - p. S273 , 2022

Link: https://doi.org/10.1016/..

2

HSD1 Treatment With Dual and Triple Therapy in Chronic Obst..:

Janson, C ; Hernando Platz, J ; Soulard, S...
Value in Health. 25 (2022) 12 - p. S273 , 2022

Link: https://doi.org/10.1016/..

3

Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidon..:

Rinciog, C. ; Diamantopoulos, A. ; Gentilini, A....
PharmacoEconomics - Open. 4 (2020) 3 - p. 449-458 , 2020

Link: https://doi.org/10.1007/..

4

PRS30 Cost-Effectiveness of the Fixed-Dose Combination Tiot..:

Hoogendoorn, M. ; Corro Ramos, I. ; Soulard, S....
Value in Health. 23 (2020) - p. S722 , 2020

Link: https://doi.org/10.1016/..

5

PRS19 BURDEN OF DISEASE OF FIBROSING INTERSTITIAL LUNG DISE..:

Wuyts, W. ; Rømhild Davidsen, J. ; Kilpeläinen, M....
Value in Health. 22 (2019) - p. S875-S876 , 2019

Link: https://doi.org/10.1016/..

6

PSY105 - COST-UTILITY OF NINTEDANIB VERSUS PIRFENIDONE FOR ..:

Soulard, S.
Value in Health. 21 (2018) - p. S454 , 2018

Link: https://doi.org/10.1016/..

7

Systematic Review of The Cost-Effectiveness of Medicines Fo..:

Soulard, S ; Wammes, K ; Picavet, E..
Value in Health. 20 (2017) 9 - p. A555 , 2017

Link: https://doi.org/10.1016/..

8

Market Access of Nintedanib for Idiopathic Pulmonary Fibros..:

Picavet, E ; Soulard, S ; Druez, C.
Value in Health. 20 (2017) 9 - p. A566 , 2017

Link: https://doi.org/10.1016/..

9

Potential Savings Achieved Through Switching COPD Patients ..:

Fens, T ; Postma, MJ ; Voorhaar, M..
Value in Health. 20 (2017) 9 - p. A650 , 2017

Link: https://doi.org/10.1016/..

10

Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitami..:

Schoenherr, N ; Soulard, S ; Crespo, C..
Value in Health. 19 (2016) 7 - p. A651 , 2016

Link: https://doi.org/10.1016/..

11

Cost-utility of nintedanib vs. Pirferidone in the treatment..:

Soulard, S ; Crespo, C
Value in Health. 19 (2016) 7 - p. A555 , 2016

Link: https://doi.org/10.1016/..

12

I-PreFer Study: A Discrete Choice Experiment to Explore Pat..:

Hollmen M ; Wijsenbeek M ; Bromilow T...
https://www.dovepress.com/i-prefer-study-a-discrete-choice-experiment-to-explore-patient-caregiv-peer-reviewed-fulltext-article-PPA. , 2023

Link: https://doaj.org/article..

13

I-PreFer Study: A Questionnaire to Explore Patient, Caregiv..:

Hollmen M ; Bromilow T ; Smith AB...
https://www.dovepress.com/i-prefer-study-a-questionnaire-to-explore-patient-caregiver-and-pulmon-peer-reviewed-fulltext-article-PPA. , 2023

Link: https://doaj.org/article..

14

Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidon..:

Rinciog, C ; Diamantopoulos, A ; Gentilini, A...
boreal:226674. , 2020

Link: http://hdl.handle.net/20..

15

Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidon..:

Rinciog, C ; Diamantopoulos, A ; Gentilini, A...
boreal:225959. , 2020

Link: http://hdl.handle.net/20..